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Aims: To compare type 2 diabetes (T2D) patients included in a Diabetes Integrated Management 
(DIM) program with those followed in Diabetes Specialized Care (DSC), investigating differences 
in general characteristics, changes in clinical outcomes, and factors related with the inclusion in the 
DIM program. 
Methods: T2D patients living in the ASLTO3 district and included into the DIM program, a shared 
disease management between general practitioners and diabetes specialists, from 2008 to 2014 were 
compared with T2D patients living in the same district and in charge of the local DSC. 
Demographic, anthropometric and clinical data for both groups of patients were obtained from the 
electronic records of DSC. 
Results: 1326 DIM patients were compared with 3494 DSC patients. A higher proportion of 
females was observed among DIM patients than among DSC patients. DIM patients were older, 
more frequently in therapy with diet only or with oral hypoglycemic, and had HbA1c and creatinine 
lower than DSC patients. The analyses of changes in clinical parameters during the study period 
showed a good and statistically significant improvement of most parameters, independently of the 
inclusion in DIM or DSC, with the exception of creatinine level. 
Conclusions: Integrated Management is an efficient and effective way to achieve good longterm 




Type 2 diabetes mellitus (T2D) is a chronic condition responsible for 1.5 million deaths and 20 
million disability adjusted years lost yearly, and increasing costs for the National Health Systems 
worldwide [18,28,30].  
Patients with diabetes need continuous care and monitoring of the disease, which are generally 
provided by diabetes specialized centers (DSC). It is indeed commonly believed that care in DSC 
assures good outcomes [1].  
However, in recent years the need to limit health care costs for chronic conditions experienced in 
most western countries has promoted the opportunity to shift the care of diabetes patients to general 
practitioners following an integrated care model [26,27]. Moreover, several studies suggested that 
specialized centers do not allow better outcomes for patients with diabetes than primary care 
generalists [2,6,9–11,13,16,19,23,25].  
In Italy, T2D accounts for more than 3 million patients and the number increases each year 
[7,14,17]. Since 2003, the Ministry of Health included diabetes among the priority areas of 
intervention of the National Health Plan committing the regions to fight the disease through the 
activities of the National Health Service. The 2005–2007 National Prevention Plan promoted the 
adoption of chronic disease management programs across the country. The ‘‘Gaining Health” 
project, a comprehensive strategy for fighting non-communicable diseases, was then launched in 
accordance with the countries of the WHO Regional Office Europe and the European Union. In this 
framework, the Italian Centre for Disease Prevention and Control, and the Istituto Superiore di 
Sanita` promoted the IGEA initiative, a strategy for implementing chronic disease integrated 
management interventions for people with diabetes reorienting healthcare services to prevent 
disabilities, favouring primary care, and increasing the self management of persons with chronic 
diseases [12,15].  
Piedmont is a 4.4million inhabitants region in North West of Italy. Patients with diabetes are about 
283,000, and most are affected by T2D [3]. Diabetes care and assistance are in charge of 25 
specialized centers and of general practitioners (GPs) of the National Health System. Since 2008, a 
regional protocol promoted the shift of diabetes care from specialized centers to GPs. Patients with 
T2D in stable metabolic control can be included in the Diabetes Integrated Management (DIM) 
model of care: they are followed by their GPs with regular laboratory controls and quarterly visits, 
and they access DSC on a yearly base or in case of acute conditions. The participation of the GPs to 
the DIM protocol is on a voluntary basis, with the provision of an economic incentive per each 
patient included in the program [21].  
The aim of this study was to compare the T2D patients of the ASLTO3 Health Care district in 
northwest Italy included in the DIM program with those followed by DSC by investigating 
differences in general characteristics at baseline and at follow-up, changes in clinical outcomes, and 
factors related with the inclusion in the DIM program.  
 
2. Subjects, materials and methods  
 
The list of T2D patients living in the ASLTO3 Health Care district and included into the DIM 
program from 1st September 2008 to 31st December 2014 was extracted from the DIM Regional 
Database. Data extraction was limited to 31
st
 December 2014 in order to have at least one year 
follow-up for all patients. Patients were included in the DIM program by their GPs, according to the 
inclusion and exclusion criteria as defined by the regional protocol. Inclusion criteria: age >18 
years; type 2 diabetes. Exclusion criteria: type 1 diabetes; gestational diabetes; secondary diabetes. 
Data on T2D patients living in the ASLTO3 Health Care district and in charge of the local DSC 
(San Luigi Gonzaga University Hospital Diabetes Outpatient Clinic), satisfying inclusion and 
exclusion criteria for the DIM program but not included into the DIM program, were extracted from 
the DSC database. 
To ensure the comparability of DIM and DSC groups, only patients with a visit at San Luigi 
Gonzaga DSC after 1
st
 September 2007 (baseline) and at least one follow-up visit by 31st December 
2015 were considered. Following these criteria, 1326 DIM patients in charge of 150 general 
practitioners and 3494 T2D patients in charge of the San Luigi Gonzaga DSC but not included in 
DIM were available for the analyses.  
Demographic, anthropometric and clinical data for both groups of patients were obtained from the 
electronic records of San Luigi Gonzaga DSC that included data on baseline and yearly follow-ups 
of the DIM patients and data on scheduled visits of the other DSC T2D patients not included in the 
DIM program. For all patients information was retrieved on demographic data, date of T2D 
diagnosis, date of first and last control at the DSC, drug treatment, clinical measurements at 
baseline and at last control, including: height, weight, BMI, systolic and diastolic blood pressure, 
HbA1c, creatinine, triglycerides, total cholesterol, HDL cholesterol, non-HDL cholesterol, and LDL 
cholesterol according to Friedewald’s equation [8].  
 
2.1. Statistical analysis  
 
Characteristics of DIM and DSC patients at first visit were described through proportions, means 
and SD. Differences between the groups in socio-demographic and clinical characteristics at first 
visit were analyzed through univariate and multivariate logistic regression analyses calculating 
Crude and Adjusted Odds Ratios (OR) and 95% Confidence Intervals, thus identifying factors 
related with the inclusion in DIM vs DSC. Significance level was set at p < 0.05. After checking co-
linearity among variables, all indicators statistically significant in the univariate analysis were 
included in the adjusted model. Variables correlated with r > 0.60 were excluded from the model. 
Weight and BMI were correlated with r = 0.71; LDL cholesterol and non-HDL cholesterol were 
correlated with total cholesterol (r = 0.72 and r = 0.76 respectively); LDL cholesterol and non-HDL 
cholesterol were correlated each other (r = 0.82). Among these variables, BMI and non-HDL 
cholesterol were chosen for the inclusion in the model. Gender, age at diagnosis, therapy, BMI, 
HbA1c, triglycerides, HDL cholesterol, non-HDL cholesterol and creatinine were finally included 
in the model.  
Normality distribution of clinical indicators was tested using the Kolgomorov-Smirnov test. All 
variables violated the normality assumption. Therefore, differences between groups were assessed 
through Wilcoxon sum rank test. Differences in changes of clinical indicators in the two groups 
were then compared calculating % change at follow-up out of the baseline level, and the differences 
from first to last visit were assessed through Wilcoxon signed rank test.  
 
3. Results  
 
3.1. Baseline characteristics and differences between DIM and DSC patients  
 
Baseline general and clinical characteristics of patients in DIM and DSC are described in Table 1.  
In both groups, the majority of patients were males (57.6% vs 42.3%), and the proportion of males 
was higher in the DSC (58.9%) vs the DIM group (54.3%).  
Patients in DIM were slightly older than those in DSC (mean age 58.2 vs 56.0 years) and more 
frequently were in therapy with diet only (26% vs 14.7%) or with oral hypoglycemic drugs (56.3% 
vs 52.3%), whilst less frequently took insulin (10.4% vs 21.4%) or the association of insulin and 
hypoglycemic drugs (7.4% vs 11.5%).  
DIM patients weighted less than DSC ones (mean weight 78.8 vs 80.7 kg) and their BMI was lower 
(mean 29.2 vs 29.7). According to BMI, a higher proportion of patients affected by severe obesity 
were observed among DSC patients (14.2% vs 11.4%).  
HbA1c% was lower among DIM patients (mean 7.4%-54 mmol/mol vs 7.9%-63 mmol/mol). A 
higher proportion of DIM patients had values lower than 7.5%-58 mmol/mol (69.3% vs 56.2%) and 
a lower proportion had values higher than 9.5%-80 mmol/mol (8.9% vs 15.7%).  
As regards creatinine, baseline mean levels were similar but a higher proportion of DIM than DSC 
patients showed values <1.1 mg/dl (85.7% vs 79.4%).  
No differences were observed between the two groups in diastolic blood pressure. On the contrary, 
a higher proportion of DIM subjects had normal (120–139 mmHg) systolic blood pressure (51.4% 
vs 47.8% of DSC patients).  
For both DIM and DSC groups, the majority of patients showed a good control of triglycerides; 
however, in DSC group a higher proportion of patients with values >200 mg/dl was observed 
(19.9% vs 16%). Also for the other parameters of lipid control no big differences were observed 
between the two groups, apart from a slightly lower proportion of patients with high HDL 
cholesterol values among DSC vs DIM subjects (16.7% vs 18.5%).  
In conclusion, DIM patients apparently showed at baseline a lower severity of clinical conditions 
and a better glycemic control than DSC patients.  
 
3.2. Factors related to the inclusion in DIM vs DSC  
 
Univariate analysis showed that female gender, age at T2D diagnosis older than 50 years, being in 
therapy with diet only, a lower weight and BMI, HbA1c <6.5%-48 mmol/mol, creatinine values 
<1.1 mg/dl, triglycerides <200 mg/dl, and HDL cholesterol >40 mg/dl were significantly related 
with the inclusion in DIM vs DSC (Table 2).  
Female gender, older age at T2D diagnosis, being in therapy with diet only, lower values of HbA1c 
and creatinine were confirmed by the multivariate adjusted analyses as factors significantly related 
with the probability to be included in DIM vs DSC model of care. By converse, males, subjects on 
oral hypoglycemic drugs, insulin or the association of oral hypoglycemic drugs and insulin, having 
HbA1c >8.5%-69 mmol/mol and creatinine >1.1 mg/dl, had a lower probability to be included in 
DIM by their GPs (Table 2).  
 
3.3. Changes in clinical parameters from baseline to follow-up  
 
The analyses of changes in clinical parameters between first and last follow-up visit during the 
study period showed a good and statistically significant improvement of most parameters in the 
entire study population, independently of the inclusion in DIM or DSC model of care (Figs. 1 and 2, 
Table 3).  
The exception was creatinine level, that worsened both among patients in DIM (+1.1% of the 
starting level) and among those in DSC (+4.0% of the starting level); the difference in worsening 
between the groups was not statistically significantly (p = 0.41) (Table 3). In both groups, the 
worsening of creatinine was not statistically significant (p = 0.66 for DIM patients, and p = 0.15 for 
DSC patients) (Fig. 2).  
On the contrary, consistent with the worst baseline level of the DSC group, the improvement of 
HbA1c was significantly higher among DSC patients than among DIM ones (5.8% of the starting 
level vs 4.0%, p = 0.056) (Table 3). In both groups the improvement of HbA1c was statistically 
significant (Fig. 1).  
 
4. Discussion  
 
In our study, a higher proportion of females was observed among patients included by their GPs in 
DIM than among patients under DSC. Patients in DIM were of older age, more frequently in 
therapy with diet only or with oral hypoglycemic, and with baseline level of HbA1c and creatinine 
lower than patients under DSC. Overall, DIM patients showed at baseline a lower severity of 
clinical conditions and a better glycemic control than DSC patients. The analyses of changes in 
clinical parameters during the study period showed a good and statistically significant improvement 
of most parameters, independently of the inclusion in DIM or DSC, with the exception of creatinine 
level that worsened (although not significantly) in both groups, and HbA1c that improved more 
among DSC than DIM patients. The last results are expected, considering the different 
characteristics of patients in the two groups at baseline and the expected worsening of the disease. 
The lower severity of diabetes in patients included in DIM is consistent with previous studies: it is a 
common and expected observation that patients followed by specialized clinics have a more severe 
disease than those followed by their GPs.  
Previous studies reported a higher proportion of males, younger age, more frequent therapy with 
insulin and overall worse health status among DSC vs DIM patients [4,5,13,16,20]. In a historical 
period where governments try to reduce health costs introducing new models of care based on 
integrated actions between general practitioners and specialized professionals, such result is actually 
desired. It reduces the overload of patients at DSC, shifting patients without complications and in 
good metabolic control to GPs: this appears as a rational choice that helps specialized clinics to 
dedicate to patients with more severe disease. Moreover, the Italian model of integrated care, as 
encouraged by the Ministry of Health, includes yearly controls, or more if needed, at DSC, thus 
promoting the integration of care and the communication between GPs and DSC: if applied, such 
actions improve continuity of care. The promotion of this model has several advantages for the 
national and regional public health system: reduction of costs, improvement of appropriateness and 
reduction of waiting lists. Previous studies comparing specialized with not specialized or integrated 
care showed the similarity of outcomes for diabetes patients followed by one or the other 
professionals [6,9–11,13,16,19,25], or even better outcomes for the integrated management scheme 
[2,23,29]. Our study confirms these findings: outcomes did not differ among patients in DIM or 
DSC aside from worsening of creatinine and improvement of HbA1c, two results that are explained 
by the differences in clinical parameters and severity of the conditions at baseline. It is commonly 
observed, independently from the scheme of care applied, that metabolic control improves soon 
after the patients is diagnosed and treated [11,13,22–25]; that patients with poorly controlled 
diabetes benefit the most [22,24]; and that, despite overall improvement of clinical parameters, 
diabetes care is unable to prevent increase of creatinine over time [13]. In light of effectiveness of 
the health care action, it appears of great importance that patients show an immediate improvement 
of clinical conditions and parameters as soon as they are taken in charge. At long follow-up this will 
end in a lower number of hospital admissions, lower complication rates, and longer survival [2,29]. 
For the overall functioning of the system and the achievement of positive clinical outcomes, a 
training of GPs to the new model of care, the provision of specific guidelines, and the use of new 
technologies to share information can be useful.  
Our study has some strength. All patients treated in DIM in the district of ASLTO3 were compared 
to all patients treated in DSC in the same district, so that the generalizability of the findings is 
ensured. The number of patients included in the study was high. The clinical data were complete for 
both populations. Outcomes data were available at long follow-up. Differences between the two 
samples were investigated through a multivariate model, adjusting for confounding factors.  
Our study has also some limits. First of all, the observational design does not allow evaluating the 
effectiveness of the DIM versus standard DSC care. Selection of less severe patients for the 
inclusion in DIM ca not be completely adjusted in multivariate analysis, and residual confounding 
may be present. This bias could have masked the possible superior results of DSC. Finally, we 
could not analyse strong outcomes such as mortality and hospital accesses.  
In conclusion, our study confirms that the introduction of an integrated model of care is an efficient 
way to ensure good quality of diabetes care. The increasing burden of diabetes experienced by 
western countries calls for a more efficient and coordinated health care delivery. The social and 
economic costs related to chronic complications need timely effective prevention and care. The 
consistency of positive outcomes of integrated care provided by GPs and specialized care is 
reassuring and confirms the crucial role of GPs in helping the system to curb costs and 
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